Hence the serum HGF levelhas been proposed as an independent prognostic marker in myeloma, in AML, andin CML but in MPNs, such studies have not yet been performed in large cohorts of patients. Here, HGF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.